Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (6)
  • 2024 (6)
  • 2023 (15)
  • 2022 (13)
  • 2021 (3)

Subject

  • Drug Trafficking (430)
  • Synthetic drugs (201)
  • Guns/Weapons (123)
  • Arrests/Convictions - Major (79)
  • Overdose (57)
  • Gangs (54)
  • Prescription Drugs (53)
  • Guilty Plea (49)
  • Task Forces/Task Force Officers (47)
  • Major Law Enforcement Operation (37)
  • Seizures (Drugs/Property) (37)
  • Pharmaceuticals/Pharmacists/Physicians (34)
  • OCDETF/Task Force (30)
  • HIDTA (28)
  • Fake Pills (27)
  • Money Laundering (21)
  • Take Back Day (19)
  • Fentanyl Awareness (13)
  • Press Conferences (10)
  • Extraditions (9)
  • Fentanyl Free America (9)
  • Terrorism (8)
  • International/Foreign Operations (7)
  • Counterfeit Pills (6)
  • Outreach/Drug Prevention (6)
  • Prevention/Education - DEA websites GSAD, JTT etc (6)
  • Public and Media Affairs - also see Congressional Affairs (6)
  • Dark Web- Internet Trafficking (5)
  • Campaigns (2)
  • One Pill Can Kill (2)
  • Cartel (1)
  • Critical Incident (1)
  • El Paso Intelligence Center (1)
  • Intergovernmental Affairs (1)
  • Narcoterrorism (1)
  • Diversion Division (43)

Drug Name

  • Oxycodone (8)
  • Fentanyl (2)
  • Opioids (2)
  • Cocaine (1)
  • GHB (1)

Field Division

  • Atlanta (13)
  • Chicago (18)
  • Dallas (6)
  • Detroit (1)
  • El Paso (11)
  • Houston (17)
  • Los Angeles (4)
  • Louisville (3)
  • Miami (10)
  • New England (36)
  • New Jersey (16)
  • New Orleans (8)
  • New York (27)
  • Omaha (4)
  • Phoenix (4)
  • Rocky Mountain (7)
  • San Diego (3)
  • San Francisco (10)
  • Seattle (25)
  • Sede (11)
  • St. Louis (11)
  • Washington, DC (34)
Clear All Results
43 Results - Showing 1 to 10
PRESS RELEASE

Manhattan Men Charged with Conspiracy to Distribute Millions of Doses of Deadly Gamma-Butyrolactone (GBL), A Chemical Often Times Attributed to Sexual Assaults.

Special Agent in Charge of the New York Enforcement Division of the Drug Enforcement Administration (“DEA”), Farhana Islam, and United States Attorney for the Southern District of New York, Jay Clayton, announced today the unsealing of an Indictment charging MARK DYGDON and RODRIGO CASTRO in connection with the defendants’ distribution...
PRESS RELEASE

DEA and United Against Fentanyl Announce National Partnership for Walk for Lives 2026

NEWARK, N.J. –The U.S. Drug Enforcement Administration and United Against Fentanyl (UAF) announced a national partnership in support of DEA’s Fentanyl Free America initiative. Walk for Lives 2026 is a coordinated series of more than 100 family-led community events across the United States on July 11, 2026. These events aim...
PRESS RELEASE

Camden County Pharmacist Charged with Illegally Dispensing Oxycodone

CAMDEN, N.J. – Special Agent in Charge of the Drug Enforcement Administration's New Jersey Field Division Towanda R. Thorne-James and U.S. Attorney for the District of New Jersey Robert Frazer announced a Camden County pharmacist was charged in an indictment with unlawfully distributing oxycodone, and his wife was separately charged...
PRESS RELEASE

Brooklyn Woman Charged with Attempting to Steal Opioid Prescriptions from Hempstead Assisted Living Facility

MINEOLA, N.Y. – DEA New York Enforcement Division Special Agent in Charge Farhana Islam and Nassau County District Attorney Anne T. Donnelly announced that a Brooklyn woman was charged with attempted criminal possession of a controlled substance and forgery for allegedly sending falsified oxycodone prescriptions to a pharmacy to obtain...
PRESS RELEASE

New Yorkers Remove Over 14,000 Pounds of Unwanted Medications During DEA’s National Prescription Drug Take Back Day

NEW YORK, N.Y. – The United States Drug Enforcement Administration’s two New York Divisions, the New York Enforcement Division and the New York Task Force Division, announce the collection of over 14,000 pounds of unwanted, expired and/or medications. On April 25, 2026, the U.S. Drug Enforcement Administration joined 4,306 law...
PRESS RELEASE

Glen Head Doctor and His Son Charged with Illegally Selling Prescriptions for Controlled Substances

MINEOLA, N.Y. – Drug Enforcement Administration New York Enforcement Division Special Agent in Charge Farhana Islam and Nassau County District Attorney Anne T. Donnelly announced that a Glen Head doctor and his son were charged with allegedly selling dozens of prescriptions for opioids, amphetamines, and benzodiazepines without a legitimate medical...
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...
PRESS RELEASE

Owner Of New Jersey Company Admits to Evading U.S. Customs Duties and His Company Agrees to a $3.1 Million Settlement Agreement

NEWARK, N.J. – The owner of a New Jersey company today admitted mislabeling hazardous chemicals entering the United States and evading customs duties, DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today. George Volpe, 60, of Roseland, New Jersey, owner...
PRESS RELEASE

Nurse Practitioner Sentenced to 70 Months for Unlawful Drug Distribution

ALBANY, NEW YORK – Danielle Simonson, age 52, of Fort Ann, New York, was sentenced today to 70 months in prison for distributing controlled substances outside the course of professional practice and for no legitimate medical purpose. United States Attorney Carla B. Freedman; Special Agent in Charge Frank A. Tarentino...
PRESS RELEASE

Nurse Practitioner Arrested for Unlawful Drug Distribution

ALBANY, NEW YORK – Christopher Viagrande, age 41, of Latham, New York, was arrested earlier this week and charged with distributing controlled substances outside the course of professional practice and for no legitimate medical purpose. United States Attorney Carla B. Freedman and Special Agent in Charge Frank A. Tarentino III...

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster